These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29754289)

  • 1. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.
    Hörbelt T; Tacke C; Markova M; Herzfeld de Wiza D; Van de Velde F; Bekaert M; Van Nieuwenhove Y; Hornemann S; Rödiger M; Seebeck N; Friedl E; Jonas W; Thoresen GH; Kuss O; Rosenthal A; Lange V; Pfeiffer AFH; Schürmann A; Lapauw B; Rudovich N; Pivovarova O; Ouwens DM
    Diabetologia; 2018 Sep; 61(9):2054-2065. PubMed ID: 29754289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
    Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
    J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(10):16966-16970. PubMed ID: 30807659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP1 is a novel adipokine linked to inflammation in obesity.
    Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
    Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Wnt1-inducible Signaling Pathway Protein-1 in Obese Children and Adolescents.
    Wang AR; Yan XQ; Zhang C; Du CQ; Long WJ; Zhan D; Ren J; Luo XP
    Curr Med Sci; 2018 Oct; 38(5):868-874. PubMed ID: 30341522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous and Visceral Adipose Tissue Secretions from Extremely Obese Men and Women both Acutely Suppress Muscle Insulin Signaling.
    Sarr O; Strohm RJ; MacDonald TL; Gaudio N; Reed JK; Foute-Nelong J; Dyck DJ; Mutch DM
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus.
    Sahin Ersoy G; Altun Ensari T; Subas S; Giray B; Simsek EE; Cevik O
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):942-946. PubMed ID: 27267804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
    Dropmann A; Alex S; Schorn K; Tong C; Caccamo T; Godoy P; Ilkavets I; Liebe R; Gonzalez D; Hengstler JG; Piiper A; Quagliata L; Matter MS; Waidmann O; Finkelmeier F; Feng T; Weiss TS; Rahbari N; Birgin E; Rasbach E; Roessler S; Breuhahn K; Tóth M; Ebert MP; Dooley S; Hammad S; Meindl-Beinker NM
    Biochem Biophys Res Commun; 2024 Nov; 732():150409. PubMed ID: 39033550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway.
    Lu S; Liu H; Lu L; Wan H; Lin Z; Qian K; Yao X; Chen Q; Liu W; Yan J; Liu Z
    Eur J Pharmacol; 2016 Oct; 788():90-97. PubMed ID: 27321870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.
    Valverde AM; Burks DJ; Fabregat I; Fisher TL; Carretero J; White MF; Benito M
    Diabetes; 2003 Sep; 52(9):2239-48. PubMed ID: 12941762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.
    Sahin Ersoy G; Altun Ensari T; Vatansever D; Emirdar V; Cevik O
    Gynecol Endocrinol; 2017 Feb; 33(2):119-123. PubMed ID: 27690684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
    Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of WISP1 circulating level and tissue expression following metabolic and bariatric surgery using rat model.
    Kitaghenda FK; Wang J; Li T; Hong J; Yao L; Zhu X
    Updates Surg; 2024 Dec; 76(8):2841-2849. PubMed ID: 39407056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells.
    Fernandez-Ruiz R; García-Alamán A; Esteban Y; Mir-Coll J; Serra-Navarro B; Fontcuberta-PiSunyer M; Broca C; Armanet M; Wojtusciszyn A; Kram V; Young MF; Vidal J; Gomis R; Gasa R
    Nat Commun; 2020 Nov; 11(1):5982. PubMed ID: 33239617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH.
    Hedjazifar S; Khatib Shahidi R; Hammarstedt A; Bonnet L; Church C; Boucher J; Blüher M; Smith U
    Diabetes; 2020 Mar; 69(3):331-341. PubMed ID: 31882566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver.
    Nakagawa Y; Aoki N; Aoyama K; Shimizu H; Shimano H; Yamada N; Miyazaki H
    Zoolog Sci; 2005 Feb; 22(2):169-75. PubMed ID: 15738637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance.
    Pachori AS; Madan M; Nunez Lopez YO; Yi F; Meyer C; Seyhan AA
    Obesity (Silver Spring); 2017 Apr; 25(4):697-703. PubMed ID: 28240822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.